Teduglutide Therapy in 2 Patients With Short-Bowel Syndrome and Familial Adenomatous Polyposis

JPEN J Parenter Enteral Nutr. 2021 May;45(4):839-843. doi: 10.1002/jpen.2001. Epub 2020 Sep 7.
No abstract available

Keywords: growth factors; oncology; organ transplantation; outcomes research/quality; parenteral nutrition; short-bowel syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adenomatous Polyposis Coli* / drug therapy
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Peptides / therapeutic use
  • Short Bowel Syndrome* / drug therapy

Substances

  • Gastrointestinal Agents
  • Peptides
  • teduglutide